Latest filing published 26 Jan 2024 for Adicet Bio, Inc., €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Francesco Galimi is a declared insider of Adicet Bio, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 10 filings, for trades running from 4 June 2021 to 24 January 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 26 January 2024 with a share grant (€11k) in Adicet Bio, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations